Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors

Table 1

Sample characteristics: doctors using MT and integrative cancer care.

	Number	Years
		Median (range)
Doctors	35
Men	30
Women	5
Age (years)		55 (40–84)
Specialty of doctor
Oncology, hematology	8
Internal medicine, pulmonology, or gastroenterology	17
General practitioner	12
Pediatrician	3
Gynecology	1
Neurology	1
Research doctor	1
Work experience as a physician		26 (11–57)
Cancer patients treated with ME/year: median (range)	270 (13–1,000)
Using intravenous ME application	29
Regularly	3
Rarely	6
Setting
Hospital or outpatient clinic	21
Resident doctor	14
Working in or collaborating with cancer centers	35
Country of workplace
Germany	22
Switzerland	6
England, France, Sweden, Italy, Czech Republic, Egypt, Peru	1 from each country

Some doctors had several specialties and are mentioned twice.